Xiaoyan Hao

Xiaoyan Hao

Auto-generated profile, based on publicly available information

Xiaoyan Hao

Maternal‐Fetal Medicine Center in Fetal Heart Disease Capital Medical University; Beijing Anzhen Hospital Beijing China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2021 in Acta Radiologica
Verified
Journal Article
Closed access
PDF file
XHXiao-Yan Hao
Xiao-Yan Hao
YZYe Zhang
Ye Zhang
YZYing Zhao
Ying Zhao
XLXiaowei Liu
Xiaowei Liu
XGXiaoyan Gu
Xiaoyan Gu
YHYi-Hua He
Yi-Hua He
Background: Isolated aortic brachiocephalic artery (IABA) is a rare congenital aortic arch anomaly. It is difficult to diagnose IABA prenatally and the prevalence in the prenatal population is unknown.Purpose: To evaluate the echocardiographic characteristics and associations in fetuses with IABA.Material and Methods: We retrospectively analyzed all cases of prenatal diagnosis of IABA from January 2012 to November 2020 and reviewed the follow-up results. Copy Number Variation Sequencing (CNV-Seq) was performed using the biological specimens of the of the fetuses and family members.Results: Ten cases (10/45652, 0.022%) of IABA were identified in our center. The prevalence of the cases with isolated left subclavian artery (ILSCA) in the right aortic arch (RAA) population was 0.98% (6/613). The ILSCA was the most common isolated arch branch. All the isolated branches were on the opposite side of aortic arch in all the cases. The “ice stick” sign in the coronal section could be seen in most cases of IABA. Of the 10 cases, 8 (8/10, 80%) were associated with tetralogy of Fallot (TOF). Two cases of IABA were combined with 22q11.2 deletion syndrome.Conclusion: IABA is a rare aortic anomaly. ILSCA was the most common isolated arch branch and TOF was the most common associated intra-cardiac anomaly. The “ice stick” sign in the coronal section could indicate a diagnosis of the IABA.

1 January 2025 in Cardiovascular Therapeutics
Verified
Journal Article
Open access
SJSonghao Jia
Songhao Jia
PLPeiyi Liu
Peiyi Liu
MWMaozhou Wang
Maozhou Wang
HZHongkai Zhang
Hongkai Zhang
TLTingting Liu
Tingting Liu
WJwenjian jiang
wenjian jiang
Objective: Hyperhomocysteinemia is a risk factor for cardiovascular disease, but its impact on valve disease is lacking in research. This study was aimed at investigating the impact of hyperhomocysteinemia on rheumatic mitral valve calcification and prognosis in patients undergoing surgery. Methods: This study included 672 patients with severe rheumatic mitral valve stenosis who underwent surgery between January 2016 and December 2022. Patients were stratified by preoperative homocysteine levels. Mitral valve pathology was assessed by echocardiography and coronary CTA, with all‐cause mortality as the primary mid‐term endpoint. Results: Among this surgical cohort of 672 patients with severe rheumatic mitral stenosis, 208 (31.0%) patients were identified with hyperhomocysteinemia. Imaging assessment revealed that these patients had a higher Agatston score for mitral valve calcification (37.47 vs. 17.19, p = 0.038) after adjusting baseline data. Restricted cubic splines revealed a significant dose–response relationship, with mitral valve calcification increasing progressively with higher homocysteine levels ( p < 0.001). The Kaplan–Meier survival analysis showed that patients with hyperhomocysteinemia had significantly lower mid‐term survival rates (log‐rank p = 0.004). Through univariate and multivariate COX regression analyses, it was found that hyperhomocysteinemia was an independent risk factor affecting mid‐term postoperative survival (HR, 2.257; p = 0.048). Conclusions: In patients undergoing surgery for rheumatic heart disease, hyperhomocysteinemia was associated with the formation of rheumatic mitral valve calcification and increased mid‐term postoperative mortality. Trial Registration: Chinese Clinical Trial Registry identifier ChiCTR2200067151

3 September 2026 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
XHXiaoyan Hao
Xiaoyan Hao
SYShuang Yang
Shuang Yang
QWQiang Wang
Qiang Wang
YZYe Zhang
Ye Zhang
YHYihua He
Yihua He

1 January 2025 in International Journal of Genomics
Verified
Journal Article
Open access
JCJian Chen
Jian Chen
HSHairui Sun
Hairui Sun
LHLing Han
Ling Han
XGXiaoyan Gu
Xiaoyan Gu
XHXiaoyan Hao
Xiaoyan Hao
HLHong Li
Hong Li
Background: This study aimed to assess the pathogenicity of newly identified tuberous sclerosis Complex 1 (TSC1) and TSC2 variants, contributing definitive evidence for the diagnosis of TSC. Methods: A total of 103 TSC patients underwent TSC genetic testing using standardized protocols, and genetic testing was extended to their respective families. Analysis of genetic testing results considered clinical phenotype and gene pathogenicity based on the 2012 revision of the International Society of TSC. Results: Among participants, 12 exhibited previously unreported variants of TSC1 or TSC2 gene absent in relevant databases. All 12 clinically diagnosed TSC patients presented typical phenotypes, such as brain lesions and skin changes. Notably, there were 2 variants of TSC1 gene and 10 variants of TSC2 gene, encompassing 8 frameshift variants, 2 nonsense variants, and 2 missense variants. Conclusions: This study broadens the spectrum of variants of TSC1 and TSC2 genes, reaffirming the clinical diagnosis of patients through genetic testing.